Continuous-infusion doxorubicin in the treatment of primary hepatic malignancies of childhood

Keyphrases

• Doxorubicin 100%
• Continuous Infusion 100%
• Primary Hepatic Tumors 100%
• Cardiotoxicity 50%
• Tumor Size 50%
• Stable Disease 50%
• Response to Therapy 50%
• Nausea 50%
• Cumulative Dose 50%
• Tumor Marker 50%
• Vomiting 50%
• Myelosuppression 50%
• Positive Responses 50%

Medicine and Dentistry

• Cancer 100%
• Continuous Infusion 100%
• Doxorubicin 100%
• Neoplasm 50%
• Tumor Marker 50%
• Bone Marrow Suppression 50%
• Nausea and Vomiting 50%
• Cardiotoxicity 50%
• Diseases 50%
• Side Effect 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Doxorubicin 100%
• Cardiotoxicity 50%
• Nausea and Vomiting 50%
• Neoplasm 50%
• Bone Marrow Suppression 50%
• Tumor Marker 50%
• Diseases 50%
• Side Effect 50%